CytoTools

Latest

CytoTools: DPOLC also effective against influenza viruses

According to the company, CytoTool’s active ingredient DPOLC has shown positive results in test series for its effectiveness on influenza…

Read More »
Latest

Cytotools: tension before the general meeting

In India, Cytotools has its first revenue with DermaPro. A phase III study has started in Europe. The pandemic creates…

Read More »
Latest

CytoTools now produces DermaPro active ingredient DPOLC in Saarbr├╝cken

CytoTools can now produce the active ingredient DPOLC, which is used in the skin drug DermaPro, among other things, at…

Read More »
Latest

CytoTools share: COVID-19 news causes price jump – the details

On Friday morning there is a significant price jump in the CytoTools share. This is currently quoted in XETRA trading…

Read More »
Latest

Cytotools: New CFO and EUR 6 million for development

Cytotools announces the appointment of a Chief Financial Officer. Marc Herwick will hold the newly created position on the board…

Read More »
Latest

CytoTools: Centaur starts marketing DermaPro in India

CytoTools announces the start of the marketing of the wound healing drug DermaPro in India. Marketing partner Centaur Pharmaceuticals will…

Read More »
Latest

CytoTools: Black numbers from 2023

A product for the treatment of diabetic foot syndrome and open leg is expected to be launched in India soon.…

Read More »
Latest

CytoTools: Patent-News brings share price jump

A clear price gain can be observed today for the CytoTools share. In XETRA trading on the Frankfurt Stock Exchange,…

Read More »
Back to top button